Co-founder of shire pharmaceuticals appointed as chief operating officer of klotho neurosciences

Klto strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates new york, ny, october 15, 2024 – prism mediawire – klotho neurosciences, inc. (nasdaq: klto), a u.s.
KLTO Ratings Summary
KLTO Quant Ranking